Exhibit 99.1
REGULATED INFORMATION
Publication relating to transparency notifications
Mont-Saint-Guibert (Belgium), November 18, 2024, 10:30 pm CET / 4:30 pm ET – In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) announces that it received a transparency notification as detailed below.
On November 15, 2024, Nyxoah received a transparency notification from ResMed Inc. following the passive crossing of a threshold. Based on the notification, ResMed Inc. holds 1,727,864 voting rights, representing 4.62% of the total number of voting rights on October 9, 2024 (37,389,015).
The notification dated November 5, 2024 contains the following information:
| · | Reason for the notification: passive crossing of a threshold |
| · | Notification by: a person that notifies alone |
| · | Persons subject to the notification requirement: |
| | - | ResMed Inc. (with address at 9001 Spectrum Center Boulevard, San Diego, CA 92123, USA) |
| · | Date on which the threshold was crossed: October 9, 2024 |
| · | Threshold that is crossed: 5% |
| · | Denominator: 37,389,015 |
| · | Notified details: |
A) Voting rights | Previous notification | After the transaction |
| # of voting rights | # of voting rights | % of voting rights |
Holders of voting rights | | Linked to securities | Not linked to the securities | Linked to securities | Not linked to the securities |
ResMed Inc. | 1,619,756 | 1,727,864 | | | |
| TOTAL | 1,727,864 | 0 | 4.62% | 0.00% |
| · | Full chain of controlled undertakings through which the holding is effectively held: No indirect holding of voting securities. ResMed Inc. is not a controlled entity. |
*
* *
Contact:
Nyxoah
John Landry, CFO
IR@nyxoah.com